daily
weekly
Friday, June 5, 2015
Regeneron (REGN) reaches a new 52-week and all-time high
Regeneron Pharmaceuticals Inc. (REGN) reached a new 52-week and all-time high after the FDA released a preliminary review of an experimental Regeneron-Sanofi cholesterol drug saying the drug effectively lowers bad LDL cholesterol and is generally well-tolerated.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment